We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has placed three board directors—Cristina Ortega Duran, Andy Richards, and Simon Sturge—for Our Future Health Trading Ltd., the trading subsidy of Our Future Health, a U.K.-based collaborative health research program. “It has been our privilege to work with Coulter Partners over the last six months with our recruitment of three non-executive
Life sciences recruiting specialist Coulter Partners has expanded with the addition of Hannah Musisi as executive director based in London. She will support the firm’s work in the digital health sector, working closely with Ian Coyne, executive director. “As part of our broad offering across science, technology and innovation, we have been working more and
Life sciences recruiting specialist Coulter Partners and Differing Minds, a neurodiversity training and consulting specialist, have formed a partnership agreement. “We are extremely interested to learn about neuroinclusive recruitment and how we can attract neurodivergent people, not only in recruitment of our own talent but with clients, too,” said Bianca Coulter, CEO of Coulter Partners. “This exciting partnership
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Raffaele Baffa as chief medical officer of CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors. “Dr. Baffa is a medical professional and industry veteran with extensive experience in clinical development and translational
Coulter Partners recently partnered with MTIP and Coramaze Technologies (Coramaze) and is pleased to announce the placement of Rob ten Hoedt as Chair of Coramaze’s Board of Directors. Coramaze Technologies is a pre-commercial medical technology company, focused on developing a novel tricuspid valve repair system, called Tripair™, a minimally invasive solution for treating tricuspid regurgitation
Coulter Partners successfully completed a search assignment for Clinical Partners and is pleased to announce the placement of Luis De Miguel Puig as Chief Data and Technology Officer (CDTO). Clinical Partners is a UK leading provider of mental health services which works both privately and with the NHS to help people and families experiencing mental
Coulter Partners successfully completed a search assignment for iOnctura and is pleased to announce the placement of Dr. Mark Velleca as Chair of the Board of Directors. iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules. Dr. Mark Velleca is currently the CEO and Board Chair of Black Diamond Therapeutics (BDTX) and
Coulter Partners successfully completed a search assignment for Altimmune Inc. (Nasdaq: ALT), and is pleased to announce the placement of biopharmaceutical industry executives Teri Lawver and Jerry Durso to its Board of Directors. Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual
Coulter Partners announces the strengthening of its management team with the promotion of Penny Sadler as Managing Partner. Penny Sadler brings 30 years of global search experience to her new role, with a specialization in medtech, diagnostics, and life sciences tools. She also possesses deep expertise in Benelux pharmaceuticals, as well as biotech startups and
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024